Tumor vasculature is ever changing partly in response to high tumor VEGF concentrations causing aberrant neo-vascularization [41] and solid-phase stress resulting in compression of fragile vasculature [42], both of which contribute to reduced blood flow. This evidence concerns the gene VEGFA and neoplasm.